These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8706862)

  • 1. A covalently bound catalytic intermediate in Escherichia coli asparaginase: crystal structure of a Thr-89-Val mutant.
    Palm GJ; Lubkowski J; Derst C; Schleper S; Röhm KH; Wlodawer A
    FEBS Lett; 1996 Jul; 390(2):211-6. PubMed ID: 8706862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A catalytic role for threonine-12 of E. coli asparaginase II as established by site-directed mutagenesis.
    Harms E; Wehner A; Aung HP; Röhm KH
    FEBS Lett; 1991 Jul; 285(1):55-8. PubMed ID: 1906013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary crystallographic studies of Y25F mutant of periplasmic Escherichia coli L-asparaginase.
    Kozak M; Jaskólski M; Röhm KH
    Acta Biochim Pol; 2000; 47(3):807-14. PubMed ID: 11310979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of active site mutant of antileukemic L-asparaginase reveals conserved zinc-binding site.
    Borek D; Kozak M; Pei J; Jaskolski M
    FEBS J; 2014 Sep; 281(18):4097-111. PubMed ID: 25040257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the role of threonine and serine residues of E. coli asparaginase II by site-specific mutagenesis.
    Derst C; Henseling J; Röhm KH
    Protein Eng; 1992 Dec; 5(8):785-9. PubMed ID: 1287659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of autocatalytic activation of plant-type L-asparaginases.
    Michalska K; Hernandez-Santoyo A; Jaskolski M
    J Biol Chem; 2008 May; 283(19):13388-97. PubMed ID: 18334484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of the specific function of the conserved threonine triad responsible for human L-asparaginase autocleavage and substrate hydrolysis.
    Nomme J; Su Y; Lavie A
    J Mol Biol; 2014 Jun; 426(13):2471-85. PubMed ID: 24768817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid residues adjacent to the catalytic cavity of tetramer L-asparaginase II contribute significantly to its catalytic efficiency and thermostability.
    Long S; Zhang X; Rao Z; Chen K; Xu M; Yang T; Yang S
    Enzyme Microb Technol; 2016 Jan; 82():15-22. PubMed ID: 26672444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase I.
    Yun MK; Nourse A; White SW; Rock CO; Heath RJ
    J Mol Biol; 2007 Jun; 369(3):794-811. PubMed ID: 17451745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific mutagenesis of Escherichia coli asparaginase II. None of the three histidine residues is required for catalysis.
    Wehner A; Harms E; Jennings MP; Beacham IR; Derst C; Bast P; Röhm KH
    Eur J Biochem; 1992 Sep; 208(2):475-80. PubMed ID: 1521538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering the substrate specificity of Escherichia coli asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248.
    Derst C; Henseling J; Röhm KH
    Protein Sci; 2000 Oct; 9(10):2009-17. PubMed ID: 11106175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of the acyl-enzyme complexes of the Staphylococcus aureus beta-lactamase mutant Glu166Asp:Asn170Gln with benzylpenicillin and cephaloridine.
    Chen CC; Herzberg O
    Biochemistry; 2001 Feb; 40(8):2351-8. PubMed ID: 11327855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of stability and enzymatic activity by site-directed mutagenesis of E. coli asparaginase II.
    Verma S; Mehta RK; Maiti P; Röhm KH; Sonawane A
    Biochim Biophys Acta; 2014 Jul; 1844(7):1219-30. PubMed ID: 24721562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallization and preliminary crystallographic studies of a new crystal form of Escherichia coli L--asparaginase II (Ser58Ala mutant).
    Kozak M; Jaskólski M
    Acta Crystallogr D Biol Crystallogr; 2000 Apr; 56(Pt 4):509-11. PubMed ID: 10739936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erwinia chrysanthemi L-asparaginase: epitope mapping and production of antigenically modified enzymes.
    Moola ZB; Scawen MD; Atkinson T; Nicholls DJ
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):921-7. PubMed ID: 7945221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic Role of the Substrate Defines Specificity of Therapeutic l-Asparaginase.
    Anishkin A; Vanegas JM; Rogers DM; Lorenzi PL; Chan WK; Purwaha P; Weinstein JN; Sukharev S; Rempe SB
    J Mol Biol; 2015 Aug; 427(17):2867-85. PubMed ID: 26142822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization and preliminary crystallographic studies of five crystal forms of Escherichia coli L-asparaginase II (Asp90Glu mutant).
    Kozak M; Borek D; Janowski R; Jaskólski M
    Acta Crystallogr D Biol Crystallogr; 2002 Jan; 58(Pt 1):130-2. PubMed ID: 11752789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy.
    Swain AL; Jaskólski M; Housset D; Rao JK; Wlodawer A
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1474-8. PubMed ID: 8434007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
    Ardalan N; Mirzaie S; Sepahi AA; Khavari-Nejad RA
    Med Hypotheses; 2018 Mar; 112():7-17. PubMed ID: 29447943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of a mobile loop at the active site of Escherichia coli asparaginase.
    Aung HP; Bocola M; Schleper S; Röhm KH
    Biochim Biophys Acta; 2000 Sep; 1481(2):349-59. PubMed ID: 11018727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.